β¨ Medicines Schedules
2 APRIL
NEW ZEALAND GAZETTE
965
Folic acid; in medicines containing more than 500 micrograms of folic acid per recommended daily dose.
Glucagon.
Hydrocortisone; and hydrocortisone acetate; in medicines for dermatological use containing 0.5% or less by weight of hydrocortisone base and in a quantity of not more than 15 grams or 15 millilitres per container.
Hydroquinone; in medicines containing more than 2% of hydroquinone.
Idoxuridine; in medicines containing 0.5% or less of idoxuridine for dermatological use.
Indomethacin; in medicines for external use containing 1% or less of indomethacin.
Ipecacuanha.
Jaborandi; alkaloids of; and its salts; in medicines containing 0.5% or more of the alkaloids of jaborandi.
Ketoconazole; for dermatological use.
Lobelia; alkaloids of; and their salts.
Loratidine.
Mefenamic acid; and its salts; in solid dose forms of 250 mg or less and in a pack containing not more than 20 tablets or capsules for the treatment of dysmenorrhoea.
Mequitazine.
Nicotinamide; in medicines for transdermal use.
Nicotine; in medicines for external use.
Noradrenaline; and its salts.
Paracetamol; except where specified elsewhere in this notice.
Phenazone.
Piroxicam; in medicines for external use containing 1% or less of piroxicam.
Polygeline.
Potassium chloride; except in medicines for oral rehydration therapy.
Potassium perchlorate.
Salicylic acid; in medicines containing more than 12.5% of salicylic acid.
Selenium; and compounds of selenium; in medicines for external use containing more than 2.5% of selenium; and in medicines for internal use where the recommended daily dose exceeds 150 micrograms of selenium.
Sennosides.
Sulphadiazine; and its salts; in medicines for external use when in pack sizes containing 50 g or less of sulphadiazine.
Terbinafine; for external use.
Thiomersal.
Yohimbe; alkaloids of; and their salts.
Fourth Schedule
General Sale Medicines
Aconite; alkaloids of; and their salts; in medicines for external use containing less than 0.2% of the alkaloids of aconite.
Adrenal extract; in dermatological medicines containing 0.02% or less of ketosteroids.
Aescin; in medicines for external use.
Aloes; in medicines for external use.
Aluminium; and its salts; in medicines for external use.
Barium sulphate.
Benzoyl peroxide; in medicines for external use containing 5% or less of benzoyl peroxide.
Beta carotene; in medicines containing 18 mg or less per recommended daily dose.
Bioallethrin; in medicines for external use.
Butoxyethyl nicotinate.
Cade oil; in medicines for external use.
Calcium glucono-galacto-gluconate.
Carbaryl; in medicines for external use, containing 2% or less or carbaryl.
Carbenoxolone; and its salts; compounds of carbenoxolone; in medicines for external use.
Cardamom; compound tincture; aromatic tincture.
Catechu.
Chorhexidine.
Chlorphenesin.
Chymotrypsin.
Clioquinol; in medicines for external use.
Crocus sativus; extracts of.
Crotamiton.
2,4-Dichlorobenzyl alcohol.
Dequalinium; and its salts.
Di-iodohydroxyquinoline; in medicines for external use.
Dibromopropamide isethionate; except for ophthalmological use.
Diethylamine salicylate.
Dioctyl sodium sulphosuccinate.
Diphenamil; and its salts.
Ethyl nicotinate.
Ethyl salicylate.
Fenticlor; in medicines for external use.
Fibrinolysin; in medicines for external use.
Folic acid; in medicines containing 500 micrograms or less per recommended daily dose.
Glycol salicylate.
Guaiphenesin; in medicines containing 2% or less of guaiphenesin.
Haloproglin.
Halquinol; in medicines for external use.
Heparins; in medicines for external use.
Hexetidine; in medicines for external but not vaginal use.
Hexyl nicotinate.
Histamine acid phosphate; in medicines containing 0.5% or less of histamine acid phosphate.
8-hydroxyquinoline; and its halogenated and alkyl derivatives and their salts; in medicines for external but not vaginal use.
Hyaluronidase; for external use.
Hydroxocobalamin; in medicines containing 50 micrograms or less of hydroxocobalamin per daily dose.
Intrinsic factor.
Iodine; in medicines for external use.
Iodoform.
Maldison; in medicines for external use containing 2% or less of maldison.
Menthyl valerate.
Methyl nicotinate.
Nonylic acid; and its derivatives.
Pancreatin.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1992, No 45
NZLII —
NZ Gazette 1992, No 45
β¨ LLM interpretation of page content
π₯
Third Schedule of Pharmacy-Only Medicines
(continued from previous page)
π₯ Health & Social WelfarePharmacy-only medicines, Classification, Prescription
π₯ Fourth Schedule of General Sale Medicines
π₯ Health & Social WelfareGeneral sale medicines, Classification, Over-the-counter